CONCEPTS OF NANO EMULSION BASED DELIVERY SYSTEM
Abstract
Nanoemulsions are advanced colloidal drug delivery systems consisting of two immiscible liquids stabilized by surfactants and co-surfactants, with droplet sizes typically ranging from 20 to 200 nm. Their nanoscale dimensions provide a large interfacial surface area, resulting in improved drug solubilization, enhanced stability, and increased bioavailability compared with conventional emulsions. Nanoemulsions have emerged as promising carriers for the delivery of poorly water-soluble drugs, particularly Biopharmaceutics Classification System (BCS) Class II and IV compounds. These systems enhance drug absorption, facilitate lymphatic transport, reduce first-pass metabolism, and improve therapeutic efficacy in oral, topical, and other delivery routes. This review highlights the fundamental principles of nanoemulsion-based drug delivery systems, including their classification into oil-in-water (O/W), water-in-oil (W/O), and bicontinuous nanoemulsions. The role of formulation components such as oils, surfactants, co-surfactants, and hydrophilic–lipophilic balance (HLB) values in achieving optimal stability and performance is discussed. Various preparation techniques, including high-pressure homogenization, ultrasonication, microfluidization, spontaneous emulsification, and phase inversion methods, are reviewed with respect to their advantages and limitations. The significance of pseudo-ternary phase diagrams in formulation optimization and nanoemulsion region identification is also addressed. Furthermore, key characterization parameters such as droplet size, polydispersity index, zeta potential, morphology, viscosity, drug entrapment efficiency, in vitro drug release, and stability studies are summarized. Overall, nanoemulsions represent a versatile and effective platform for enhancing drug delivery and improving therapeutic outcomes in modern pharmaceutical applications.
References
2. McClements DJ. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 2012;8:1719–1729.
3. Smith IJ, Aversa Z, Alamdari N, Petkova V, Hasselgren PO. Sepsis increases the expression and activity of the transcription factor Forkhead Box O1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Int J Biochem Cell Biol. 2010;42:701–711.
4. Li F, Mahato RI. RNA interference for improving the outcome of islet transplantation. Adv Drug Deliv Rev. 2011;63:47–68.
5. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Chow GK, Goetz MP, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179:2136–2140.
6. Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM. Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter. 2006;18:R635–R666.
7. Pey CM, Maestro A, Solé I, González C, Solans C, Gutiérrez JM. Optimization of nano-emulsions prepared by low-energy emulsification methods at constant temperature using a factorial design study. Colloids Surf A Physicochem Eng Asp. 2006;288:144–150.
8. Kahn HA, Medalie JH, Balogh M, Groen JJ, Riss E. Diet and serum cholesterol. Am J Clin Nutr. 1989;50:177–178.
9. Lacombe C. Resistance to erythropoietin. N Engl J Med. 1996;334:660–662.
10. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278–287.
11. Komaiko JS, McClements DJ. Formation of food-grade nanoemulsions using low-energy preparation methods: a review of available methods. Compr Rev Food Sci Food Saf. 2016;15:331–352.
12. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.
13. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010;5:1595–1616.
14. Shakeel F, Ramadan W, Shafiq S, Soliman M. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007;8:E104.
15. Solé I, Maestro A, González C, Solans C, Gutiérrez JM. Optimization of nano-emulsion preparation by low-energy methods in an ionic surfactant system. Langmuir. 2006;22:8326–8332.
16. Shah P, Bhalodia D, Shelat P. Nanoemulsion: a pharmaceutical review. Syst Rev Pharm. 2010;1:24–32.
17. Safaya M, Rotliwala YC. Nanoemulsions: a review on low energy formulation methods, characterization, applications and optimization technique. Mater Today Proc. 2020;27:454–459.
18. Mahdi Jafari S, He Y, Bhandari B. Nano-emulsion production by sonication and microfluidization: a comparison. Int J Food Prop. 2006;9:475–485.
19. Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for formulation of nanoemulsion drug delivery system: a review. Prev Nutr Food Sci. 2019;24:225–234.
20. Chien CR, Lai MS, Chen THH. Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach. Lung Cancer. 2008;62:215–220.
21. Solans C, Solé I. Nano-emulsions: formation by low-energy methods. Curr Opin Colloid Interface Sci. 2012;17:246–254.
22. Ren G, Sun Z, Wang Z, Zheng X, Xu Z, Sun D. Nanoemulsion formation by the phase inversion temperature method using polyoxypropylene surfactants. J Colloid Interface Sci. 2019;540:177–184.
23. Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv. 2015;22:455–466.
24. Tadros TF, Vandamme A, Levecke B, Booten K, Stevens CV. Stabilization of emulsions using polymeric surfactants based on inulin. Adv Colloid Interface Sci. 2004;108-109:207–226.
25. Forgiarini A, Esquena J, González C, Solans C. Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir. 2001;17:2076–2083.
26. Hanif N, Iqbal S, Durkin M, Kelly D, Gater R, et al. Translation of the Social Difficulties Inventory (SDI-21) into three South Asian languages and preliminary evaluation of SDI-21 (Urdu). Qual Life Res. 2011;20:431–438.
27. Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter. 2016;12:2826–2841.
28. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57.
29. Ocker H, Wenzel V, Schmucker P, Dörges V. Effectiveness of various airway management techniques in a bench model simulating a cardiac arrest patient. J Emerg Med. 2001;20:7–12.
30. Zhang R, Zhang Z, Zhang H, Decker EA, McClements DJ. Influence of emulsifier type on gastrointestinal fate of oil-in-water emulsions containing anionic dietary fiber (pectin). Food Hydrocoll. 2015;45:175–185.
31. Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108-109:303–318.
32. Ali MS, Alam MS, Alam N, Siddiqui MR. Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran J Pharm Res. 2014;13:1125–1140.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.

.